FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea - BioSpace

FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea  BioSpace

LOUISVILLE, Ky., Aug. 26, 2019 /PRNewswire/ -- US WorldMeds, LLC announced today that the U.S. Food and Drug Administration (FDA) approved the ...



Comments

Popular posts from this blog

22 Essential Oils for Skin Conditions and Types, and How to Use ...

Syphilis: Symptoms, Diagnosis, Treatment, and Prevention